Hakkı KAHRAMAN, Gonca Çayır KELEŞ, Selen Burçak ŞİMŞEK, Burcu Özkan ÇETİNKAYA, Diyar KÖPRÜLÜ

The Role of Periodontal Disease on Acute Phase Proteins in Patients With Coronary Heart Disease and Diabetes

Aims: Chronic infections such as periodontal disease (PD) have been suggested to be a risk factor for coronary heart disease (CHD). Elevated levels of acute phase proteins are associated with increased risk for cardiovascular events in both healthy individuals and patients with known CHD. This study aimed to investigate the role of PD on C-reactive protein (CRP) and fibrinogen levels in patients with either CHD or type 2 diabetes. Materials and Methods: 80 subjects were evaluated in four groups: individuals with CHD+PD (group 1; n: 20), individuals with type 2 diabetes+PD (group 2; n: 20), individuals with PD without any systemic disease (group 3; n: 20), and healthy individuals (group 4; n: 20). Blood samples were taken at the time of periodontal examination. Results: Demographic characteristics between the four groups and periodontal parameters between groups 1, 2, and 3 were not statistically different (P > 0.05). CRP and fibrinogen levels were increased in groups 1, 2, and 3 compared to those in group 4 (P < 0.05). Conclusions: The patients in groups 1, 2, and 3 may have risk for future cardiovascular events. Findings of the present study seem to indicate that periodontitis contributes to systemic inflammation due to higher CRP and fibrinogen levels. Physicians should be aware that maintaining periodontal health might be effective in reducing cardiovascular events risk in periodontitis subjects with/without CHD and diabetes.

Anahtar Kelimeler:

Cardiovascular risk, C-reactive protein, fibrinogen, periodontal disease, periodontitis

The Role of Periodontal Disease on Acute Phase Proteins in Patients With Coronary Heart Disease and Diabetes

Keywords:

Cardiovascular risk, C-reactive protein, fibrinogen, periodontal disease, periodontitis,

PDF

___

1. Stamler J. Research related to risk factors. Circulation 1979; 60: 1575-1587.
2. Emingil G, Buduneli E, Aliyev A, Akilli A, Atilla G. Association between periodontal disease and acute myocardial infarction. J Periodontol 2000; 71: 1882-1886.
3. Montebugnoli L, Servidio D, Miaton RA, Prati C, Tricoci P, Melloni C. Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors. J Clin Periodontol 2004; 31: 25-29.
4. Wu T, Trevisan M, Genco RJ, Falkner KL, Dorn JP, Sempos CT. Examination of the relation between periodontal health status and cardiovascular risk factors: serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen. Am J Epidemiol 2000; 151: 273-282.
5. American Academy of Periodontology. Periodontal disease as a potential risk factor for systemic diseases (position paper). J Periodontol 1999; 69: 841-850.
6. Sahingur SE, Sharma A, Genco RJ, De Nardin E. Association of increased levels of fibrinogen and the -455G/A fibrinogen gene polymorphism with chronic periodontitis. J Periodontol 2003; 74: 329-337.
7. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000; 71: 1554-1560.
8. Ajwani S, Mattila KJ, Tilvis RS, Ainamo A. Periodontal disease and mortality in an aged population. Spec Care Dentist 2003; 23: 125-130.
9. Ide M, McPartlin D, Coward PY, Crook M, Lumb P, Wilson RF. Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses. J Clin Periodontol 2003; 30: 334-340.
10. Armitage GC. Periodontal infections and cardiovascular disease-- how strong is the association? Oral Dis 2000; 6: 335-350.
11. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS. Acutephase inflammatory response to periodontal disease in the US population. J Dent Res 2000; 79: 49-57.
12. D'Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004; 83: 156-160.
13. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic Creactive protein level. J Periodontol 2001; 72: 1221-1227.
14. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237-242.
15. Kuroe A, Taniguchi A, Sekiguchi A, Ogura M, Murayama Y, Nishimura F et al. Prevalence of periodontal bacterial infection in non-obese Japanese type 2 diabetic patients: relationship with Creactive protein and albuminuria. Horm Metab Res 2004; 36: 116-118.
16. Schwahn C, Volzke H, Robinson DM, Luedemann J, Bernhardt O, Gesch D et al. Periodontal disease, but not edentulism, is independently associated with increased plasma fibrinogen levels. Results from a population-based study. Thromb Haemost 2004; 92: 244-252.
17. Itagaki M, Kubota T, Tai H, Shimada Y, Morozumi T, Yamazaki K. Matrix metalloproteinase-1 and -3 gene promoter polymorphisms in Japanese patients with periodontitis. J Clin Periodontol 2004; 31: 764-769.
18. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957; 17: 237-246.
19. Listgarten MA. Nature of periodontal diseases: pathogenic mechanisms. J Periodontal Res 1987; 22: 172-178.
20. D'Aiuto F, Ready D, Tonetti MS. Periodontal disease and Creactive protein-associated cardiovascular risk. J Periodontal Res 2004; 39: 236-241.
21. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996; 67: 1123-1137.
22. Syrjanen J. Vascular diseases and oral infections. J Clin Periodontol 1990; 17: 497-500.
23. Mattila K, Vesanen M, Valtonen V, Nieminen M, Palosuo T, Rasi V et al Effect of treating periodontitis on C-reactive protein levels: a pilot study. BMC Infect Dis 2002 Dec 10; 2: 30.
24. Iwamoto Y, Nishimura F, Soga Y, Takeuchi K, Kurihara M, Takashiba S et al. Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adiponectin levels in patients with chronic periodontitis. J Periodontol 2003; 74: 1231-1236.
25. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. Creactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-334.
26. Saito T, Murakami M, Shimazaki Y, Oobayashi K, Matsumoto S, Koga T. Association between alveolar bone loss and elevated serum C-reactive protein in Japanese men. J Periodontol 2003; 74: 1741-1746.
27. Lantz MS, Allen RD, Bounelis P, Switalski LM, Hook M. Bacteroides gingivalis and Bacteroides intermedius recognize different sites on human fibrinogen. J Bacteriol 1990; 172: 716- 726.
28. Perez RL, Roman J. Fibrin enhances the expression of IL-1 beta by human peripheral blood mononuclear cells. Implications in pulmonary inflammation J Immunol. 1995; 154: 1879-1887.
29. Walzog B, Weinmann P, Jeblonski F, Scharffetter-Kochanek K, Bommert K, Gaehtgens P. A role for beta(2) integrins (CD11/CD18) in the regulation of cytokine gene expression of polymorphonuclear neutrophils during the inflammatory response. FASEB J 1999; 13: 1855-1865.
30. Koenig W. Heart disease and the inflammatory response. BMJ 2000; 321: 187-188.
31. Fong IW. Infections and their role in atherosclerotic vascular disease. J Am Dent Assoc 2002; 133: 7-13.
32. Deliargyris EN, Madianos PN, Kadoma W, Marron I, Smith SC Jr, Beck JD et al. Periodontal disease in patients with acute myocardial infarction: prevalence and contribution to elevated Creactive protein levels. Am Heart J 2004; 147: 1005-1009.
33. Nery EB, Meister F Jr, Ellinger RF, Eslami A, McNamara TJ. Prevalence of medical problems in periodontal patients obtained from three different populations. J Periodontol 1987; 58: 564- 568.